Scarica l'app Stockscreener
52.99
0.25%
0.13
Dopo l'orario di chiusura:
52.87
-0.12
-0.23%
Metsera Inc Borsa (MTSR) Ultime notizie
Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer - TipRanks
What machine learning models say about Metsera Inc.Sell Signal & Daily Growth Stock Investment Tips - newser.com
Is Metsera Inc. stock near bottom after declineQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
How to manage a losing position in Metsera Inc.Market Sentiment Report & Community Trade Idea Sharing Platform - newser.com
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years - The Motley Fool
Real time alert setup for Metsera Inc. performance2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
What Fibonacci levels say about Metsera Inc. reboundJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
How Metsera Inc. stock reacts to Fed rate cutsWeekly Stock Summary & Consistent Growth Equity Picks - newser.com
IP Group: Metsera deal highlights hidden value, say analysts - Proactive financial news
IP Group shares fly on back of Metsera & Pfizer news - BusinessCloud
IP Group shares climb 9% on potential royalties from Pfizer’s $7.3bn Metsera deal - Proactive financial news
IP Group notes potential income from Metsera obesity drugs - MarketScreener
IP Group Poised for Potential Royalty Windfall from Metsera’s Obesity Drug Pipeline - AskTraders.com
IP Group eyes potential royalties from obesity drug - The Armchair Trader
IP Group eyes future royalties from obesity drug candidates following Pfizer/Metsera deal - Proactive financial news
IP Group’s Edge in Obesity Drugs: Pfizer-Metsera Deal Insight - Kalkine Media
IP Group Sees Revenue Potential From Metsera Obesity Drug Deal - DirectorsTalk Interviews
IP Group Anticipates Revenue Boost from Metsera’s Obesity Drug Development - TipRanks
REGIP Group PLCPotential income from Metsera obesity drugs - TradingView
Metsera (MTSR): Evaluating Valuation After a 48% One-Month Share Price Surge - Yahoo Finance
Metsera (NASDAQ:MTSR) Receives Sell (D) Rating from Weiss Ratings - MarketBeat
Metsera Inc. stock trend forecastJuly 2025 Action & Smart Allocation Stock Tips - newser.com
How to integrate Metsera Inc. into portfolio analysis toolsQuarterly Profit Summary & AI Enhanced Trading Signals - newser.com
Pfizer Aims To Close Gap On Obesity Drugs With Metsera 09/23/2025 - MediaPost
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates UNP, MTSR, SCS on Behalf of Shareholders - The Malaysian Reserve
Novo Nordisk’s liver deal misses bigger ailment - Reuters
What data driven models say about Metsera Inc.’s futureJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Does Metsera Inc. show high probability of reboundSwing Trade & Accurate Intraday Trading Signals - newser.com
Will Metsera Inc. rebound enough to break even2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
Applying Elliott Wave Theory to Metsera Inc.Weekly Stock Analysis & Technical Pattern Based Signals - newser.com
Pfizer: Mastering The Art Of The Deal With MetseraUpgraded To Buy (NYSE:PFE) - Seeking Alpha
Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Inside INdiana Business - FinancialContent
Metsera, Inc. (MTSR) Stock Analysis: Biotechnology Innovator with a 5.71% Upside Potential - DirectorsTalk Interviews
Is this a good reentry point in Metsera Inc.Exit Point & Consistent Return Investment Signals - newser.com
Is Metsera Inc. stock poised for growthWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Will earnings trigger a reversal in Metsera Inc.July 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
Is Metsera Inc. stock resilient to inflationJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles - MSN
Where Metsera’s data fit in the obesity landscape - biocentury.com
Will Metsera Inc. stock split again soonWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):